About Syneron Candela

A GLOBAL LEADER IN THE AESTHETIC MEDICAL DEVICE MARKETPLACE

 

Syneron Candela is a leading global non-surgical aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, women's intimate health, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company has a wide portfolio of trusted, leading products including UltraShape Power, VelaShape, CO2RE, CO2RE Intima, GentleLase, VBeam Perfecta, PicoWay, Profound and elōs Plus.

Founded in 2000, Syneron Candela has it’s headquarter in Wayland (Massachusetts), USA. The company markets, services and supports its products in nearly 100 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

On the 17th of July, 2017 Syneron Candela announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners.

Apax Partners is a leading global private equity advisory firm. Over its more than 30-year history, Apax Partners has raised and advised funds with aggregate commitments in excess of $46 billion*. Funds advised by Apax Partners invest in companies across four global sectors of Healthcare, Tech and Telco, Services and Consumer.  These funds provide long-term equity financing to build and strengthen industry leaders.  In the healthcare sector they have completed more than 80 investments, including in medical devices, pharmaceuticals and healthcare services. For further information about Apax Partners, please visit www.apax.com.

Geoff Crouse is the Chief Executive Officer and a member of the Board of Directors of Syneron Candela. Geoff has successfully led businesses in the life sciences sector spanning capital equipment, diagnostics and tools. Prior to joining Syneron Candela, he served as Chief Executive Officer of Cord Blood Registry from 2012 to 2015, when the company was sold to AMAG Pharmaceuticals.

Syneron Candela is now a privately held company. Their focus is on their customers’ success by building on the strength of Syneron Candela’s brands, the technology behind its products, and the high quality of the Company’s engineering and product development organization.

GENERATE
SUCCESS

with: Science. Results. Trust.

OFFICES AND DISTRIBUTORS
AROUND THE WORLD
GENERATE
SUCCESS

Grow Your Practice with Syneron Candela
This form is for physicians only. Learn more!

offices mapcircle-nacircle-eupoly

GLOBAL LOCATIONS

Syneron Inc. (USA)
3 Goodyear, Unit A Irvine California 92618 USA
Email: info@syneron.com
Tel: 866-259-6661
www.syneron-candela.com/na
Syneron, Candela, Elure, CO2RE
CONTACT
PATIENTS